MGMT Antibody (YA3828)
(Synonyms: EC 2.1.1.63)MGMT Antibody (YA3828) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to MGMT.
-
Host:
Mouse
-
Isotype:
IgG
-
Application:
WB, IHC-P, ICC/IF, FC, ELISA
-
Reactivity :
Human
-
Formulation:
Supplied in PBS with 0.05% sodium azide
-
Conjugation:
Non-conjugated
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
Applications
| Application |
WB
WB: Western Blot
|
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
FC
FC: Flow Cytometry
|
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
|---|---|---|---|---|---|
| Dilution Ratio | 1:500-1:2000 | 1:200-1:1000 | 1:200-1:1000 | 1:200-1:400 | 1:10000 |
Product Details
MGMT Antibody (YA3828) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to MGMT.
-
Host Mouse
-
Clonality Monoclonal
-
Species ReactivityHuman
-
Observed Molecular WeightObserved band size: 22 kDa
Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 22 kDa
Purified recombinant fragment of human MGMT (AA: 32-210) expressed in E. Coli.
affinity purified.
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in PBS with 0.05% sodium azide
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
MGMT encodes O6-methylguanine-DNA methyltransferase, also called AGT, a DNA repair protein that removes alkyl groups from O6-alkylguanine adducts[1]. Mechanistically, MGMT repairs cytotoxic O6-methylguanine and O6-chloroethylguanine lesions induced by methylating or chloroethylating agents, thereby limiting DNA damage signaling and alkylating-drug cytotoxicity[2][3]. In glioma, MGMT promoter methylation silences MGMT expression and predicts clinical response to alkylating agents, including temozolomide[4][5]. Compared with separate isoform targets, the retrieved literature describes MGMT/AGT as the same repair protein, so isoform-specific claims require additional evidence[1]. For experimental applications, O6-benzylguanine and O6- (4-bromothenyl) guanine have been used to inactivate MGMT, but normal-tissue MGMT inhibition can increase alkylating-drug toxicity[6].
-
Subcellular Localization
Nucleus
-
SwissProt ID
-
Synonyms
EC 2.1.1.63
Documentation
[1]. Fang Q. The Versatile Attributes of MGMT: Its Repair Mechanism, et al. The Versatile Attributes of MGMT: Its Repair Mechanism, Crosstalk with Other DNA Repair Pathways, and Its Role in Cancer. Cancers (Basel). 2024 Jan 11;16(2):331. [Content Brief]
[2]. Kaina B, et al. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst). 2007 Aug 1;6(8):1079-99. [Content Brief]
[3]. Fan CH, et al. O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas. Cell Death Dis. 2013 Oct 24;4(10):e876. [Content Brief]
[4]. Esteller M, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med. 2000 Nov 9;343(19):1350-4. [Content Brief]
[5]. Hegi ME, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005 Mar 10;352(10):997-1003. [Content Brief]
[6]. Kaina B, et al. Targeting O⁶-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy. Cell Mol Life Sci. 2010 Nov;67(21):3663-81. [Content Brief]
Powered by Bioz
